Oncoproteomic and gene expression analyses identify prognostic biomarkers for second primary malignancy in patients with head and neck squamous cell carcinoma
- 1 July 2019
- journal article
- research article
- Published by Elsevier in Laboratory Investigation
- Vol. 32 (7) , 943-956
Abstract
No abstract availableKeywords
Funding Information
- Mahidol University
- Thailand Research Fund (RSA5780065)
- National Research Council of Thailand
This publication has 48 references indexed in Scilit:
- An EMILIN1-Negative Microenvironment Promotes Tumor Cell Proliferation and Lymph Node InvasionCancer Prevention Research, 2012
- Genetic Variants in the PI3K/PTEN/AKT/mTOR Pathway Predict Head and Neck Cancer Patient Second Primary Tumor/Recurrence Risk and Response to Retinoid ChemopreventionClinical Cancer Research, 2012
- The type III inositol 1,4,5-trisphosphate receptor is associated with aggressiveness of colorectal carcinomaCell Calcium, 2010
- Keratins in health and cancer: more than mere epithelial cell markersOncogene, 2010
- Proteomic analysis of field cancerization in pharynx and oesophagus: a prospective pilot studyThe Journal of Pathology, 2010
- Local recurrences and second primary tumors from squamous cell carcinoma of the oral cavity: A retrospective analytic study of 500 patientsHead & Neck, 2009
- Universal sample preparation method for proteome analysisNature Methods, 2009
- Recommendations from the EGAPP Working Group: can tumor gene expression profiling improve outcomes in patients with breast cancer?Genetics in Medicine, 2009
- DSG3 is overexpressed in head neck cancer and is a potential molecular target for inhibition of oncogenesisOncogene, 2006
- Survival in second primary malignancies of patients with head and neck cancerThe Journal of Laryngology & Otology, 2002